QSAM Biosciences, Inc.
Biotechnology Research
Austin, Texas, United States
6 employees
- Employees
- 6
QSAM Biosciences, Inc. Overview
- Headquarters
- Austin, Texas, United States
- Website
- www.qsambio.com
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2020
- Funding
- 200.0K
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About QSAM Biosciences, Inc.
QSAM Biosciences, Inc. is a clinical stage company developing next-generation nuclear medicines for the treatment of cancer. Our lead product, Samarium-153 DOTMP (CycloSam®), is an advanced therapeutic radiopharmaceutical for multiple indications: treatment of primary bone cancer and metastatic bone cancers from the breast, prostate and lungs; bone marrow ablation; and reduction in external radiation. QSAM is not currently recruiting. To those receiving recruitment offers, this is unfortunately a scam and we advise you to cease any communications with any parties fraudulently representing QSAM.
Compare Similar Companies to QSAM Biosciences, Inc.
Telix Pharmaceuticals Limited
Pharmaceutical Manufacturing
Alpha-9 Oncology
Biotechnology Research
Clarity Pharmaceuticals
Biotechnology Research
Clovis Oncology
Biotechnology Research
Actinium Pharmaceuticals, Inc.
Biotechnology Research
Plus Therapeutics, Inc.
Pharmaceutical Manufacturing
Radiopharm Theranostics
Biotechnology Research
Monopar Therapeutics Inc.
Biotechnology Research
IsoTherapeutics
Pharmaceutical Manufacturing
Nordic Nanovector ASA
Biotechnology Research